Shionogi & Co (JP:4507) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Shionogi & Co. reports a decline in revenue and profits for the 1st quarter of FY2024 compared to the previous year, with a notable decrease in prescription drug sales partly offset by growth in overseas subsidiaries and increased royalty income. The company saw a 10.7% drop in revenue and a 28.2% reduction in profits, as it continues to invest heavily in research and development.
For further insights into JP:4507 stock, check out TipRanks’ Stock Analysis page.
